Orchid Pharma

{
  "main_header": {
    "sid": 653435,
    "name": "Orchid Pharma",
    "stock_name": "Orchid Pharma",
    "full_name": "Orchid Pharma Ltd",
    "name_url": "stocks-analysis/orchid-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "991.00",
    "chg": 2.8,
    "chgp": "0.28%",
    "dir": 1,
    "prev_price": "988.20",
    "mcapval": "5,192.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524372,
    "symbol": "ORCHPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE191A01027",
    "curr_date": "Jun 24, 03:30 PM",
    "curr_time": "08:39 AM",
    "last_traded_at": "Jun 24, 03:30 PM IST",
    "bse_nse_vol": "1.09 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 24, 2026",
    "traded_date_str": "2026 06 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/orchid-pharma-653435-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Orchid Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4066593",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OrchidPharmaLtd_technicaldot_4066593.png",
        "date": "2026-06-22 08:01:46",
        "description": "Orchid Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, despite a recent 2.77% decline in its share price. The stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish RSI readings, underscoring a nuanced outlook for investors in this small-cap pharmaceutical player."
      },
      {
        "title": "Orchid Pharma Ltd Gains 7.08%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-gains-708-5-key-factors-driving-the-weeks-momentum-4065654",
        "imagepath": "",
        "date": "2026-06-20 16:06:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> New 52-week high at Rs.969</p>\n                    <p><strong>16 Jun:</strong> Intraday high surge to Rs.1089.3 and new 52-week high at Rs.990.3</p>\n                    <p><strong>19 Jun:</strong> Formation of Golden Cross signalling potential bullish breakout</p>\n                    <p><strong>19 Jun:</strong> Week closes at Rs.981.90 (-2.77% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.917.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.981.90</div>..."
      },
      {
        "title": "Golden Cross Forms in Orchid Pharma Ltd — On a Day the Stock Fell 2.77%. What the Mixed Signals Mean",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4064133",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OrchidPharmaLtd_goldencross_4064133.png",
        "date": "2026-06-19 18:00:55",
        "description": "The 50-day moving average for Orchid Pharma Ltd has crossed above the 200-day moving average, creating a golden cross on 19 Jun 2026. Yet, the stock declined 2.77% on the same day, and the monthly technical indicators present a more cautious picture. This juxtaposition of signals calls for a detailed examination of the cross’s reliability in the current context."
      },
      {
        "title": "Orchid Pharma Ltd Surges 7.3% to Day's High of Rs 1089.3 — Outperforms Sector by 12.87 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-hits-intraday-high-with-73-surge-on-16-jun-2026-4056217",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OrchidPharmaLtd_priceRelatedfactors_4056217.png",
        "date": "2026-06-16 15:16:09",
        "description": "The Sensex advanced 0.7% on 16 Jun 2026, yet Orchid Pharma Ltd outpaced the broader market with a 7.3% gain, reaching an intraday peak of Rs 1089.3. This 12.87 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Orchid Pharma Ltd to 52-Week High of Rs 990.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-hits-new-52-week-high-at-rs9903-4055613",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OrchidPharmaLtd_priceRelatedfactors_4055613.png",
        "date": "2026-06-16 09:48:11",
        "description": "With a decisive intraday surge to Rs 990.3 on 16 Jun 2026, Orchid Pharma Ltd has reached a fresh 52-week high, marking a 33.8% gain over the past year and outpacing the Sensex’s decline of 6.35%. This milestone reflects a strong alignment of technical indicators and sustained price momentum despite a slight pullback on the day."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Orchid Pharma Ltd to 52-Week High of Rs 969",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-hits-new-52-week-high-at-rs969-4053977",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OrchidPharmaLtd_priceRelatedfactors_4053977.png",
        "date": "2026-06-15 09:54:59",
        "description": "Surging past its previous peaks, Orchid Pharma Ltd touched a fresh 52-week high of Rs 969 on 15 Jun 2026, propelled by a confluence of bullish technical indicators and sustained price momentum that has captivated market attention."
      },
      {
        "title": "Orchid Pharma Ltd Upgraded to Sell on Technical Improvement Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-upgraded-to-sell-on-technical-improvement-despite-flat-financials-4053529",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OrchidPharmaLtd_mojoScore_4053529.png",
        "date": "2026-06-15 08:04:09",
        "description": "Orchid Pharma Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 12 June 2026, driven primarily by a marked improvement in technical indicators despite persistent fundamental challenges. The pharmaceutical small-cap’s recent price surge and bullish technical signals contrast with its flat financial performance and valuation concerns, presenting a nuanced outlook for investors."
      },
      {
        "title": "Orchid Pharma Ltd Shows Technical Momentum Shift Amid Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-shows-technical-momentum-shift-amid-strong-price-rally-4053487",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OrchidPharmaLtd_technicaldot_4053487.png",
        "date": "2026-06-15 08:03:12",
        "description": "Orchid Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend, supported by a complex interplay of technical indicators. Despite a recent upgrade in its Mojo Grade from Strong Sell to Sell, the stock’s price action and momentum metrics reveal a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Orchid Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-sell-4052915",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/OrchidPharmaLtd_mojoScore_4052915.png",
        "date": "2026-06-14 10:10:04",
        "description": "Orchid Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 345,
    "sid": "653435",
    "stock_news_url": "https://www.marketsmojo.com/news/orchid-pharma-653435"
  },
  "announcements": [
    {
      "caption": "Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited And Orchid Pharma Limited",
      "datetime": "12-Jun-2026",
      "details": "Update for receipt of copy of order related to scheme of Amalgamation of Dhanuka Laboratories limited and Orchid Pharma limited",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "11-Jun-2026",
      "details": "Disclosure regarding the order passed by Goods and Service Department.",
      "source": "BSE"
    },
    {
      "caption": "Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited (Amalgamating Company) With Orchid Pharma Limited (Amalgamated Company) And Their Respective Shareholders And Creditors (The Scheme) Under Regulation 30 Of SEBI (Listing Obligati",
      "datetime": "05-Jun-2026",
      "details": "In continuation to our earlier intimation dated March 18 2026 with respect to merger petition we would like to inform that Honble National Company Law Tribunal (NCLT) on June 05 2026 i.e. today has allowed our petition sanctioning the scheme of Amalgamation and Arrangement of Dhanuka Laboratories Limited with Orchid Pharma Limited and their respective Shareholders and Creditors by virtue of which the Amalgamating Company would stand transferred to and vested in or deemed to have been transferred and vested in Amalgamated Company on a going concern basis.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Orchid Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 13 Sep 12",
          "dt": "2012-09-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Orchid Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-22 08:01:46

Orchid Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, despite a recent 2.77% decline in its share price. The stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish RSI readings, underscoring a nuanced outlook for investors in this small-cap pharmaceutical player.

Read full news article

Orchid Pharma Ltd Gains 7.08%: 5 Key Factors Driving the Week’s Momentum

2026-06-20 16:06:14

Key Events This Week

15 Jun: New 52-week high at Rs.969

16 Jun: Intraday high surge to Rs.1089.3 and new 52-week high at Rs.990.3

19 Jun: Formation of Golden Cross signalling potential bullish breakout

19 Jun: Week closes at Rs.981.90 (-2.77% on day)

Week Open

Rs.917.00

Week Close

Rs.981.90

...

Read full news article

Golden Cross Forms in Orchid Pharma Ltd — On a Day the Stock Fell 2.77%. What the Mixed Signals Mean

2026-06-19 18:00:55

The 50-day moving average for Orchid Pharma Ltd has crossed above the 200-day moving average, creating a golden cross on 19 Jun 2026. Yet, the stock declined 2.77% on the same day, and the monthly technical indicators present a more cautious picture. This juxtaposition of signals calls for a detailed examination of the cross’s reliability in the current context.

Read full news article

Orchid Pharma Ltd Surges 7.3% to Day's High of Rs 1089.3 — Outperforms Sector by 12.87 Percentage Points

2026-06-16 15:16:09

The Sensex advanced 0.7% on 16 Jun 2026, yet Orchid Pharma Ltd outpaced the broader market with a 7.3% gain, reaching an intraday peak of Rs 1089.3. This 12.87 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Broad-Based Technical Strength Lifts Orchid Pharma Ltd to 52-Week High of Rs 990.3

2026-06-16 09:48:11

With a decisive intraday surge to Rs 990.3 on 16 Jun 2026, Orchid Pharma Ltd has reached a fresh 52-week high, marking a 33.8% gain over the past year and outpacing the Sensex’s decline of 6.35%. This milestone reflects a strong alignment of technical indicators and sustained price momentum despite a slight pullback on the day.

Read full news article

Broad-Based Technical Strength Lifts Orchid Pharma Ltd to 52-Week High of Rs 969

2026-06-15 09:54:59

Surging past its previous peaks, Orchid Pharma Ltd touched a fresh 52-week high of Rs 969 on 15 Jun 2026, propelled by a confluence of bullish technical indicators and sustained price momentum that has captivated market attention.

Read full news article

Orchid Pharma Ltd Upgraded to Sell on Technical Improvement Despite Flat Financials

2026-06-15 08:04:09

Orchid Pharma Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 12 June 2026, driven primarily by a marked improvement in technical indicators despite persistent fundamental challenges. The pharmaceutical small-cap’s recent price surge and bullish technical signals contrast with its flat financial performance and valuation concerns, presenting a nuanced outlook for investors.

Read full news article

Orchid Pharma Ltd Shows Technical Momentum Shift Amid Strong Price Rally

2026-06-15 08:03:12

Orchid Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend, supported by a complex interplay of technical indicators. Despite a recent upgrade in its Mojo Grade from Strong Sell to Sell, the stock’s price action and momentum metrics reveal a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Orchid Pharma Ltd is Rated Sell

2026-06-14 10:10:04

Orchid Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News